BLBo Lu

Bo Lu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bo Lu has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Lei Yao

    Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    6 shared publications
  • Deyu Fu

    Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    5 shared publications
  • Jianhua Li

    Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    5 shared publications
  • Mingtai Gui

    Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    5 shared publications
  • Mingzhu Wang

    Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    5 shared publications
  • Xunjie Zhou

    Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    5 shared publications

Latest Publications

  • Open Access

    Huoxue Qianyang Qutan Recipe limits cardiac remodeling by regulating FUNDC1/IP3R2 signaling pathway in obese hypertensive rats

    by Chunlei Hou, Yuxiu Zhao, Yulong Ma, Xunjie Zhou, Lei Yao, Jianhua Li, Mingtai Gui, Mingzhu Wang, Xiaozhe Chen, Deyu Fu, et al.

    Obese hypertension (OBH) increases cardiovascular risk through myocardial remodeling, which is associated with disrupted mitochondrial Ca²⁺ homeostasis and dysfunction of mitochondria-associated endoplasmic reticulum membranes (MAM). Huoxue Qianyang Qutan Recipe (HQQR) has been shown to lower blood pressure in OBH, but its mechanism related to MAM remains unclear. In this study, phenotypic assessments in OBH rats included blood pressure, morphological parameters, and cardiac ultrasound. Cardiomyocyte hypertrophy and mitochondrial Ca²⁺ levels were analyzed via pathological staining (assessed using fluorescence-based staining), while MAM ultrastructure was examined by electron microscopy. Additionally, the activity of mitochondrial respiratory chain Complexes I–IV was detected in vivo to evaluate mitochondrial respiratory function. In vitro, flow cytometry was used to evaluate mitochondrial Ca²⁺, mitochondrial reactive oxygen species (mitoROS), and membrane potential. Protein levels of FUNDC1 and IP3R2 were assessed. Co-immunoprecipitation revealed an interaction between FUNDC1 and IP3R2, and further experiments with FUNDC1 siRNA knockdown and overexpression were conducted to clarify the mechanism of HQQR. Results showed that HQQR significantly lowered blood pressure, reduced left ventricular mass, and alleviated cardiomyocyte hypertrophy in OBH rats. In vivo, HQQR altered MAM structure and function, facilitated mitochondrial Ca²⁺ transport, and modulated FUNDC1 and IP3R2 expression. In vitro, HQQR reduced mitoROS and preserved mitochondrial Ca²⁺ homeostasis. Both HQQR treatment and FUNDC1 knockdown attenuated angiotensin II-induced cardiomyocyte hypertrophy and mitochondrial damage, as indicated by decreased levels of ANP, BNP, β-MHC, mitochondrial Ca²⁺, and mitoROS. In contrast, FUNDC1 overexpression diminished the protective effects of HQQR. The interaction between FUNDC1 and IP3R2 was confirmed, and the decrease in IP3R2 may be associated with ubiquitination-mediated degradation. In conclusion, HQQR mitigates MAM dysfunction in OBH-induced myocardial remodeling by regulating the FUNDC1-IP3R2 interaction and promoting ubiquitin-dependent degradation of IP3R2, thereby maintaining mitochondrial Ca²⁺ homeostasis in cardiomyocytes.

  • Association Between Dietary Inflammatory Index and Obesity-Related Hypertension: A Cross-sectional Study

    by Yunfeng Msc Li, Yulong Ma, Xunjie Zhou, Lei Yao, Jianhua Li, Mingtai Gui, Mingzhu Wang, Xiaozhe Chen, Bo Lu, Deyu Fu

    Background: Inflammation plays a significant role in the development of hypertension and obesity, and specific dietary patterns can influence systemic inflammation. However, the link between dietary inflammatory potential and obesity-related hypertension (ORH) remains unclear. Objective: In this study, our aim was to evaluate the association between the Dietary Inflammatory Index (DII) and ORH using data from the National Health and Nutrition Examination Survey 1999 to 2020. Methods: The DII, calculated from a 24-hour dietary recall questionnaire, was used to assess dietary inflammatory potential. Blood pressure was measured by trained examiners, and obesity was defined as a body mass index of 30 kg/m 2 or higher. Weighted logistic regression analysis was used to explore the association between DII and ORH. Results: Individuals with ORH exhibited a higher DII (1.58 ± 0.03) compared with hypertensive (1.41 ± 0.03) and nonhypertensive (1.34 ± 0.03) individuals. Weighted logistic regression indicated a significant positive correlation between DII and ORH. In the fully adjusted model, higher DII scores were associated with increased odds of ORH (Q2, 1.12 [0.99–1.27]; Q3, 1.34 [1.19–1.51]; Q4, 1.42 [1.26–1.61]). In addition, all-cause mortality risk significantly increased with higher DII levels in the population with ORH. Notably, the association between DII and ORH was more pronounced among non-Hispanic White individuals ( p for interaction < .05). Conclusions: Higher DII is associated with increased prevalence of ORH, as well as all-cause mortality, with non-Hispanic White individuals being more susceptible to the influence of proinflammatory diets.


  • Open Access

    A Review of the Mechanisms of Astragaloside IV and Berberine in Vascular Dysfunction Associated with Obesity and Diabetes

    by Yunfeng Li, Yulong Ma, Lei Yao, Jianhua Li, Xunjie Zhou, Mingzhu Wang, Mingtai Gui, Da Li, Xiaozhe Chen, Yidan Dong, et al.

    The global epidemic of obesity and diabetes imposes a significant strain on healthcare systems, substantially elevating the risk of vascular dysfunction and its associated complications. Astragaloside IV (AS-IV) and berberine (BBR) have demonstrated considerable promise in addressing vascular issues linked to these conditions. This review examines the mechanisms driving their vascular protective effects, drawing on evidence from preclinical studies to compare and contrast their modes of action. It explores both the unique and overlapping pathways through which they mitigate the complications of obesity and diabetes. A thorough analysis of their therapeutic potential highlights promising preclinical data and its clinical implications. However, challenges remain, such as enhancing the bioavailability of AS-IV and BBR and translating preclinical findings into robust clinical trials. This synthesis provides critical insights for advancing research and practical approaches in managing vascular dysfunction associated with obesity and diabetes.


  • Efficacy of Huoxue Qianyang Qutan Recipe on essential hypertension: A randomized, double-blind, placebo-controlled trial

    by Jun Xie, Yu-Long Ma, Ming-Tai Gui, Lei Yao, Jian-Hua Li, Ming-Zhu Wang, Xun-Jie Zhou, Yi-Fan Wang, Ming-Yi Zhao, Hui Cao, et al.


  • Open Access

    Mitophagy in hypertension-mediated organ damage

    by Yulong Ma, Xunjie Zhou, Mingtai Gui, Lei Yao, Jianhua Li, Xiaozhe Chen, Mingzhu Wang, Bo Lu, Deyu Fu

    Hypertension constitutes a pervasive chronic ailment on a global scale, frequently inflicting damage upon vital organs, such as the heart, blood vessels, kidneys, brain, and others. And this is a complex clinical dilemma that requires immediate attention. The mitochondria assume a crucial function in the generation of energy, and it is of utmost importance to eliminate any malfunctioning or surplus mitochondria to uphold intracellular homeostasis. Mitophagy is considered a classic example of selective autophagy, an important component of mitochondrial quality control, and is closely associated with many physiological and pathological processes. The ubiquitin-dependent pathway, facilitated by PINK1/Parkin, along with the ubiquitin-independent pathway, orchestrated by receptor proteins such as BNIP3, NIX, and FUNDC1, represent the extensively investigated mechanisms underlying mitophagy. In recent years, research has increasingly shown that mitophagy plays an important role in organ damage associated with hypertension. Exploring the molecular mechanisms of mitophagy in hypertension-mediated organ damage could represent a critical avenue for future research in the development of innovative therapeutic modalities. Therefore, this article provides a comprehensive review of the impact of mitophagy on organ damage due to hypertension.


  • Open Access

    Dietary inflammation index is associated with dyslipidemia: evidence from national health and nutrition examination survey, 1999–2019

    by Xiaozhe Chen, Chunlei Hou, Lei Yao, Jianhua Li, Mingtai Gui, Mingzhu Wang, Xunjie Zhou, Bo Lu, Deyu Fu

    Background and aims: This study aimed to investigate the association between the Dietary Inflammatory Index (DII) and dyslipidemia, as well as to evaluate the mortality risk associated with DII in participants with dyslipidemia. Methods: Data from the National Health and Nutrition Examination Survey database were divided into dyslipidemia and non-dyslipidemia groups. The association between DII and dyslipidemia was investigated using the weighted chi-square test, weighted t-test, and weighted logistic regression. Weighted Cox proportional hazards models were used to estimate the hazard ratios and 95% confidence intervals for all-cause and cardiovascular disease-related mortality within the dyslipidemia group. Results: A total of 17,820 participants, including 4,839 without and 12,981 with dyslipidemia were analyzed in this study. The results showed that DII was higher in the dyslipidemia group compared to the non-dyslipidemia group (1.42 ± 0.03 vs. 1.23 ± 0.04, P < 0.01). However, for energy, protein, carbohydrates, total fat, saturated fat, and iron, DII was lower in participants with dyslipidemia. Logistic regression analysis revealed a strong positive association between DII and dyslipidemia. The odds ratios for dyslipidemia from Q1 to Q4 were 1.00 (reference), 1.12 (0.96–1.31), 1.23 (1.04–1.44), and 1.33 (1.11–1.59), respectively. In participants with dyslipidemia, a high DII was associated with high all-cause and cardiovascular mortality. Conclusion: DII was closely associated with dyslipidemia. A pro-inflammatory diet may play a role in unfavorable consequences and is linked to both all-cause mortality and cardiovascular death in patients with dyslipidemia. Participants with dyslipidemia should pay attention to their anti-inflammatory dietary patterns.


  • Open Access

    Clinical Study on the Emotional Intervention of Patients with Asymptomatic and Mild Novel Coronavirus (COVID-19)

    by Bo Lu, Wenli Shi, Xunjie Zhou, Deyu Fu, Lei Duan, Xiaoli He, Wenjing You, Junwei Gu, Xinyue Zhang

    Background and Objectives: The aim was to explore the interventional effect of the traditional Chinese medicine (TCM) exercise of Tian Dan Shugan Tiaoxi on the emotions of patients with mild novel coronavirus (COVID-19). Materials and Methods: A total of 110 asymptomatic and mildly symptomatic COVID-19 patients from Hongkou Memorial Road Temporary Cabin Hospital and South Renji Hospital were selected between April 2022 and June 2022, and randomly divided into two groups: a control group and an intervention group. There were 55 participants in each group. The control group was treated with Lianhua Qingwen granules, and members of the intervention group were made to practice Tian Dan Shugan Tiaoxi (an exercise that soothes the liver and regulates emotions) every day for 5 days. The Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder questionnaire (GAD-7), and the Symptom Checklist 90 (SCL-90) were used to evaluate the data collected before and after the trial. Results: The incidence of anxiety and depression was high in the patients included in this study, at 73.64% and 69.09%, respectively. After intervention, the scores of the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder questionnaire (GAD-7) in the two groups had decreased in comparison with those recorded before intervention (p < 0.05). The PHQ-9 and GAD-7 scores in the intervention group were significantly better than those of the control group (p < 0.05). The factors of somatization, depression, anxiety, hostility, and fear in the SCL-90 in the intervention group were significantly improved after intervention, and generally, better than those in the control group (p < 0.05). Conclusions: Patients infected with novel coronavirus in shelter hospitals have different degrees of emotional abnormalities. Tian Dan Shugan Tiaoxi can reduce the anxiety and depression of people with mild novel coronavirus, and it can be practiced clinically to improve the recovery rate among infected people.